← Back to Clinical Trials
Recruiting NCT05822024

NCT05822024 Promoting Pupils' Physical Literacy

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT05822024
Status Recruiting
Phase
Sponsor Center for Clinical Research and Prevention
Condition Literacy
Study Type INTERVENTIONAL
Enrollment 336 participants
Start Date 2023-02-01
Primary Completion 2026-06-30

Eligibility & Interventions

Sex All sexes
Min Age 8 Years
Max Age 13 Years
Study Type INTERVENTIONAL
Interventions
Promoting Pupils' Physical Literacy Intervention

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 336 participants in total. It began in 2023-02-01 with a primary completion date of 2026-06-30.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

This pilot study aims to test the feasibility and acceptability of a previously developed and tested physical literacy (PL) intervention. A promising and internationally tested intervention, the Youth Physical Activity Towards Health (Y PATH), is based on the theory of PL and has proven to be effectful on children's PA levels and motor skills The Promoting Pupils' Physical Literacy (3 PL) project aims to test the feasibility and acceptability of the previously developed and tested Y-PATH intervention in a Danish context among a pupils (9 11 years of age). The hypothesis is that a revised 3 PL intervention protocol, aiming to increase pupils' PL, is ready for effectiveness testing by the end of this project.

Eligibility Criteria

Inclusion Criteria: School/class-level * Non-special needs municipal school classes * Classes that are not in other school development or research projects which would most likely influence and bias the results Pupil-level * Pupils with parents/guardians who have provided written informed consent, allowing their child to participate * Pupils who have provide an oral assessment Exclusion Criteria: * Pupils who do not live up to the inclusion criteria

Contact & Investigator

Central Contact

Peter Bentsen, PhD

✉ peter.bentsen@regionh.dk

📞 +4540824586

Principal Investigator

Peter Bentsen, PhD

PRINCIPAL INVESTIGATOR

Center for Clinical Research and Prevention

Frequently Asked Questions

Who can join the NCT05822024 clinical trial?

This trial is open to participants of all sexes, aged 8 Years or older, up to 13 Years, studying Literacy. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT05822024 currently recruiting?

Yes, NCT05822024 is actively recruiting participants. Contact the research team at peter.bentsen@regionh.dk for enrollment information.

Where is the NCT05822024 trial being conducted?

This trial is being conducted at Copenhagen, Denmark, Copenhagen, Denmark, Odense, Denmark.

Who is sponsoring the NCT05822024 clinical trial?

NCT05822024 is sponsored by Center for Clinical Research and Prevention. The principal investigator is Peter Bentsen, PhD at Center for Clinical Research and Prevention. The trial plans to enroll 336 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology